NIKKEI 225
28,879.86 +332.88 (+1.17%) HANG SENG
20,130.01 -45.61 (-0.23%) CRUDE OIL
91.19 -0.90 (-0.98%) GOLD FUTURES
1,809.40 -6.10 (-0.34%) DOW
33,761.05 +424.35 (+1.27%) BTC-GBP
20,512.30 +134.12 (+0.66%)
RWE Aktiengesellschaft (RWE.DE)
| Previous close | 42.25 |
| Open | 42.23 |
| Bid | 0.00 x 410300 |
| Ask | 0.00 x 177800 |
| Day's range | 41.60 - 42.79 |
| 52-week range | 29.67 - 43.97 |
| Volume | |
| Avg. volume | 2,029,140 |
| Market cap | 28.753B |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 14.41 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.90 (2.13%) |
| Ex-dividend date | 29 Apr 2022 |
| 1y target est | N/A |
- Globe Newswire
Real-world Evidence (RWE) Solutions Market Worth $4.9 Billion by 2029
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Real-world Evidence Solutions Market by Component, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The RWE solutions market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.9 billion by 2029Rapidly growing big data in healthcare, shift from volume to value-based care, and rising focus towards personalized healthcare are the key factors driving the growth of the global R
- Globe Newswire
Global RWE Oncology Market Research Report 2022
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "RWE Oncology Market by Component, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The RWE oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029.After a comprehensive primary and secondary research and an in-depth analysis of the market scenario, this report provides insights into key industry drivers, restraints, challenges, and oppo
- EQS Group
RWE Aktiengesellschaft: RWE raises Group earnings forecast for fiscal 2022
RWE Aktiengesellschaft / Key word(s): Change in ForecastRWE Aktiengesellschaft: RWE raises Group earnings forecast for fiscal 202227-Jul-2022 / 16:08 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.In view of the business performance in the first half of 2022, the Executive Board of RWE AG has adjusted today its earnings fore
